Sejahteraraya Anugrahjaya Tbk

SRAJ · JK · Healthcare / Medical Care Facilities

$13,000+0.00 (0.00%)

Close Sep 23, 2026 · end-of-day

Market Stats

Previous Close$13,000

Open$13,000

Day Range$13,000 – $13,000

52-Week Range$8,525 – $19,200

Volume100

Market Cap$159.11T

P/E (TTM)0.00

Forward P/E0.00

EPS$-30.94

Dividend Yield0.00%

Beta0.55

50-Day Avg$13,208

200-Day Avg$14,062.38

Price History

Open in new tab

Loading price history…

About

PT Sejahteraraya Anugrahjaya Tbk provides medical services in Indonesia. The company manages and operates hospitals under the Mayapada Hospital name for neuroscience center, uro-nephrology center, cardiovascular center, gastro hepatology center, liver center, oncology center, orthopedic center, spine and arthroplasty center, obstetrics and gynecology center, internal medicine and pulmonology, pediatric center, aesthetic center, sports injury treatment and performance center, rehabilitation center, and immunology center. The company was formerly known as PT Sejahtera Raya Anugrah and changed its name to PT Sejahteraraya Anugrahjaya Tbk in December 1992. PT Sejahteraraya Anugrahjaya Tbk was founded in 1991 and is based in Tangerang, Indonesia. PT Sejahteraraya Anugrahjaya Tbk is a subsidiary of PT Surya Cipta Inti Cemerlang.

Company Details

Sector: Healthcare
Industry: Medical Care Facilities
CEO: Mr. Navin Sonthalia
Employees: 4.84K
Headquarters: JI. Honoris Raya Kav. 6, Tangerang, Indonesia, 15117, Indonesia
Website: https://www.mayapadahospital.com

Leadership

Mr. Navin SonthaliaPresident Director · b. 1970
Ms. Victoria TahirDirector of Finance · b. 1978
Mr. Arif MualimOperational Director · b. 1969
Mr. Handoko GunawanHead of Internal Audit · b. 1958
Arie FarisandiCorporate Secretary · b. 1982

Financials

Income Statement

Line item	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	$122.18B	$149.18B	$167.48B	$194.50B	$221.47B	$340.52B	$449.07B	$576.18B	$631.68B	$806.03B	$1.00T	$1.28T	$1.92T	$1.93T	$2.50T	$3.15T	$2.59T
Cost of Revenue	$73.30B	$80.24B	$88.27B	$104.02B	$151.90B	$316.23B	$392.91B	$467.46B	$519.80B	$618.69B	$721.72B	$864.70B	$1.22T	$1.38T	$1.81T	$2.23T	$1.63T
Gross Profit	-	$68.94B	$79.21B	$90.48B	$69.58B	$24.29B	$56.16B	$108.72B	$111.88B	$187.34B	$280.29B	$419.10B	$705.03B	$557.05B	$689.33B	$916.44B	$958.28B
Operating Income	$10.74B	$8.31B	$5.88B	$19.35B	$-48.08B	$-83.17B	$-76.95B	$-75.98B	$-80.19B	$-78.24B	$-39.73B	$15.85B	$226.48B	$31.01B	$106.26B	$182.52B	$103.36B
EBITDA	-	$8.31B	$47.63B	$47.76B	$-40.16B	$-21.59B	$-22.10B	$10.70B	$6.19B	$2.16B	$28.09B	$206.92B	$455.64B	$292.99B	$437.23B	$253.76B	$484.61B
Net Income	$4.50B	$6.01B	$4.71B	$4.74B	$-55.12B	$-100.36B	$-132.17B	$-97.22B	$-100.85B	$-95.42B	$-75.77B	$-14.38B	$165.31B	$-44.19B	$-38.49B	$-23.51B	$-199.00B
Interest Expense	$0	$2.17M	$17.40B	$13.09B	$23.76B	$58.40B	$51.06B	$40.24B	$22.43B	$18.78B	$17.88B	$74.17B	$118.03B	$101.55B	$179.24B	$181.18B	$390.83B

Balance Sheet

Line item	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	$646.26B	$728.17B	$864.07B	$1.24T	$2.05T	$1.86T	$1.67T	$2.30T	$2.16T	$2.74T	$3.11T	$4.35T	$4.87T	$5.75T	$5.61T	$5.68T	$7.62T
Total Liabilities	$151.27B	$171.43B	$214.65B	$582.31B	$806.24B	$712.79B	$656.94B	$579.52B	$531.07B	$896.16B	$1.33T	$2.59T	$2.94T	$3.85T	$3.75T	$3.85T	$6.29T
Total Equity	$492.49B	$553.74B	$646.42B	$651.09B	$1.24T	$1.14T	$1.01T	$1.72T	$1.62T	$1.84T	$1.78T	$1.75T	$1.93T	$1.89T	$1.86T	$1.83T	$1.33T
Cash	$4.64B	$11.07B	$8.37B	$26.47B	$387.50B	$398.98B	$246.44B	$717.38B	$246.24B	$224.62B	$232.12B	$629.61B	$700.92B	$1.12T	$515.18B	$277.21B	$1.85T
Total Debt	$104.43B	$152.84B	$194.66B	$524.90B	$432.55B	$388.64B	$325.56B	$196.12B	$93.98B	$135.02B	$251.56B	$1.14T	$846.19B	$1.73T	$3.16T	$1.67T	$4.69T
Net Debt	$99.79B	$141.77B	$186.29B	$498.42B	$45.06B	$-10.34B	$78.33B	$-521.96B	$-152.27B	$-89.60B	$19.44B	$442.64B	$145.27B	$607.19B	$2.65T	$1.39T	$2.84T

Cash Flow

Line item	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	$9.70B	$31.10B	$46.92B	$28.37B	$7.92B	$16.21B	$16.01B	$16.14B	$15.24B	$16.24B	$75.42B	$93.88B	$336.79B	$210.47B	$55.92B	$273.25B	$129.67B
Investing Cash Flow	-	$-132.13B	$-161.21B	$-300.43B	$-171.63B	$-42.00B	$-44.10B	$-202.69B	$-407.69B	$-383.99B	$-390.53B	$-550.71B	$-468.28B	$-678.22B	$-585.39B	$-532.32B	$-612.15B
Financing Cash Flow	$163.05B	$107.47B	$111.59B	$268.05B	$551.30B	$92.41B	$-142.36B	$684.31B	$-79.16B	$175.46B	$308.15B	$854.32B	$179.24B	$885.08B	$-73.60B	$21.09B	$2.02T
Capital Expenditure	$171.69B	$132.73B	$161.63B	$300.48B	$171.75B	$42.91B	$44.77B	$202.84B	$407.77B	$409.56B	$390.72B	$550.82B	$467.19B	$659.89B	$588.60B	$532.60B	$579.61B
Free Cash Flow	-	$-101.63B	$-114.71B	$-272.11B	$-163.84B	$-26.70B	$-28.76B	$-186.69B	$-392.53B	$-393.32B	$-315.30B	$-456.94B	$-130.40B	$-449.42B	$-532.68B	$-259.35B	$-449.94B

Earnings

Report Date	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015	Mar 31, 2015	Dec 31, 2014	Sep 30, 2014	Jun 30, 2014	Mar 31, 2014	Dec 31, 2013	Sep 30, 2013	Jun 30, 2013	Mar 31, 2013	Dec 31, 2012
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	$-2.34	$-1.15	$-0.66	$-1.03	$-2.74	$0.74	$-4.73	$5.57	$7.25	$5.68	$3.33	$0.72	$-4.46	$-0.79	$-6.10	$0.36	$-0.89	$0.33	$-3.16	$-0.88	$-1.89	$-2.23	$-4.88	$-0.51	$-1.61	$-2.24	$0.06	$-5.17	$-4.88	$-1.74	$-7.77	$-3.26	$-2.57	$-2.29	$-3.15	$-4.69	$-2.24	$-8.07	$-2.41	$-2.48	$-2.60	$-5.01	$0.06
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap: $159.11T
Enterprise Value: $162.54T
Trailing P/E: 0.00
Forward P/E: 0.00
Price / Sales: 58.87
Price / Book: 146.07
EPS: $-30.94
Book Value: $89
Revenue (TTM): $2.70T
Gross Profit (TTM): $1.05T
EBITDA: $316.73B
Profit Margin: -13.99%
Operating Margin: -10.69%
Return on Equity: -29.50%
Return on Assets: -0.30%
Shares Outstanding: 12.24B
Shares Float: 1.82B
Beta: 0.55
Dividend Yield: 0.00%
Dividend Rate: $0
Payout Ratio: 0.00%